Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
White matter volume is decreased in the brain of patients with neuromyelitis optica.
Neurological disability and its association with walking impairment in multiple sclerosis: brief review.
Agreement between physician's recommendation and fitness-to-drive decision in multiple sclerosis.
Forsythiaside A Exhibits Anti-inflammatory Effects in LPS-Stimulated BV2 Microglia Cells Through Activation of Nrf2/HO-1 Signaling Pathway.
MULTIPLE SCLEROSIS: MOLECULAR MECHANISMS AND THERAPEUTIC OPPORTUNITIES.
Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis.
Mast Cell-Mediated Inhibition of Abdominal Neutrophil Inflammation by a PEGylated TLR7 Ligand.
Alemtuzumab: A new therapy for active relapsing-remitting multiple sclerosis.
MSer – A new, neutral descriptor for someone with multiple sclerosis
Axoskeletal proteins prevent oligodendrocyte from toxic injury by upregulating survival, proliferation, and differentiation in vitro.
Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores.
The refinement of genetic predictors of multiple sclerosis.
Natalizumab treatment reduces endothelial activity in MS patients.
MR imaging findings of the corpus callosum region in the differentiation between multiple sclerosis and neuromyelitis optica.
Impact of Depression, Fatigue and Disability on Quality of Life in Chinese Patients with Multiple Sclerosis.
[HTLV-1-associated myelopathy/tropical spastic paraparesis : A differential diagnosis in multiple sclerosis.]
T cells become licensed in the lung to enter the central nervous system.
Association of IL4 and IL4R polymorphisms with multiple sclerosis susceptibility in Caucasian population: A meta-analysis.
Reversible cerebral vasoconstriction syndrome associated with fingolimod treatment in relapsing-remitting multiple sclerosis three months after childbirth.
[Sexuality of men with neurologic disorders].
CD44 is required for the migration of transplanted oligodendrocyte progenitor cells to focal inflammatory demyelinating lesions in the spinal cord.
Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients.
Human papillomavirus vaccination, induced autoimmunity, and neuromyelitis optica.
A practical guide to the treatment of neuromyelitis optica.
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study.
Pages
« first
‹ previous
…
189
190
191
192
193
194
195
196
197
…
next ›
last »